Annotation Detail
Information
- Associated Genes
- FGFR2
- Associated Variants
-
FGFR2 c.110-12117T>C
(
ENST00000683211.1,
ENST00000357555.9,
ENST00000683035.1,
ENST00000346997.6,
ENST00000369061.8,
ENST00000457416.7,
ENST00000684153.1,
ENST00000356226.8,
ENST00000613048.4,
ENST00000682550.1,
ENST00000611527.1,
ENST00000359354.6,
ENST00000369056.5,
ENST00000360144.7,
ENST00000369060.8,
ENST00000358487.10,
ENST00000351936.11,
ENST00000369059.5 )
rs3803662
rs13387042
rs10941679
rs9383938
FGFR2 c.110-12117T>C ( ENST00000346997.6, ENST00000351936.11, ENST00000356226.8, ENST00000357555.9, ENST00000358487.10, ENST00000359354.6, ENST00000360144.7, ENST00000369056.5, ENST00000369059.5, ENST00000369060.8, ENST00000369061.8, ENST00000457416.7, ENST00000611527.1, ENST00000613048.4, ENST00000682550.1, ENST00000683035.1, ENST00000683211.1, ENST00000684153.1 )
rs3803662
rs13387042
rs10941679
rs9383938 - Associated Disease
- Malignant neoplasm of male breast
- Source Database
- DisGeNET
- Description
- Five SNPs showed a statistically significant association with male breast cancer: rs13387042 (2q35) (odds ratio (OR) = 1.30, p = 7.98×10⁻⁴), rs10941679 (5p12) (OR = 1.26, p = 0.007), rs9383938 (6q25.1) (OR = 1.39, p = 0.004), rs2981579 (FGFR2) (OR = 1.18, p = 0.03), and rs3803662 (TOX3) (OR = 1.48, p = 4.04×10⁻⁶).
- Pubmed
- 21949660
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.00081432561624091
- Year of publication
- 2011
Drugs